Ithaca Energy delivered a strong operational and financial performance in 2025, with average production rising to 119 kboe/d, adjusted EBITDAX of $2.0 billion, and costs reduced to $19/boe...
C&C Group plc has announced the appointment of Adam Phillips to its Board as Chief Financial Officer and Executive Director. Adam is expected to join the Company in April 2026, succeeding Andrew Andrea, who will step down from the Board in March 2026...
In Q3 FY26, Vodafone achieved strong service revenue growth across Europe and Africa, with continued momentum in Germany and Africa and good progress on the UK merger integration...
REACT Group plc has reported audited results for the year ended 30 September 2025, delivering 20% revenue growth to £24.9m and a 450-basis-point increase in gross margin to 32.1%...
For the year ended 31 December 2025, Verici Dx Plc reported unaudited revenues of $3.8m, driven by first recognised Tutivia™ revenues, increased test volumes, and expanded US reimbursement coverage...
Tern Plc notes that Device Authority, in which it holds a 25.3% stake, has announced further progress in the automotive sector, securing a new OEM customer and expanding an existing Tier 1 deployment...
Verici Dx Plc has entered into an agreement with Blue Cross and Blue Shield of Illinois to provide in-network coverage for Tutivia™, its post-kidney transplant diagnostic test...
Ithaca Energy delivered a strong operational and financial performance in 2025, with average production rising to 119 kboe/d, adjusted EBITDAX of $2.0 billion, and costs reduced to $19/boe...
C&C Group plc has announced the appointment of Adam Phillips to its Board as Chief Financial Officer and Executive Director. Adam is expected to join the Company in April 2026, succeeding Andrew Andrea, who will step down from the Board in March 2026...
In Q3 FY26, Vodafone achieved strong service revenue growth across Europe and Africa, with continued momentum in Germany and Africa and good progress on the UK merger integration...
REACT Group plc has reported audited results for the year ended 30 September 2025, delivering 20% revenue growth to £24.9m and a 450-basis-point increase in gross margin to 32.1%...
For the year ended 31 December 2025, Verici Dx Plc reported unaudited revenues of $3.8m, driven by first recognised Tutivia™ revenues, increased test volumes, and expanded US reimbursement coverage...
Tern Plc notes that Device Authority, in which it holds a 25.3% stake, has announced further progress in the automotive sector, securing a new OEM customer and expanding an existing Tier 1 deployment...
Verici Dx Plc has entered into an agreement with Blue Cross and Blue Shield of Illinois to provide in-network coverage for Tutivia™, its post-kidney transplant diagnostic test...
